• Amyra Biotech AG

    BS
    active
    Check credit rating Timeline
    Check credit ratingCredit rating
    Register number: CH-170.3.037.708-6
    Sector: Research and development

    Age of the company

    12 years

    Turnover in CHF

    PremiumPremium

    Capital in CHF

    203'547

    Employees

    PremiumPremium

    Active brands

    0

    Reports for Amyra Biotech AG

    *displayed reports are examples
    preview

    Credit rating information

    Evaluation of credit rating with traffic light as risk indicator and other helpful data about the company.
    Find out more
    preview

    Economic information

    Comprehensive information about the economic situation of a company.
    Find out more
    preview

    Payment behaviour

    Assessment of the payment behaviour based on past invoices.
    Find out more
    preview

    Payment collection information

    Overview of current and past debt enforcement proceedings.
    Find out more
    preview

    Company dossier as PDF

    Contact information, changes in the company, turnover and employee figures, management, ownership, shareholding structure and other company data.
    Retrieve company dossier

    About Amyra Biotech AG

    • Amyra Biotech AG in Basel is a Company limited by shares (AG) from the sector «Research and development». Amyra Biotech AG is active.
    • Amyra Biotech AG has 6 persons entered in its management.
    • All past changes can be viewed and saved as a PDF under the section «Notifications». The last change in the commercial register was made on 14.07.2025.
    • The Enterprise Identification Number of the company Amyra Biotech AG is the following: CHE-321.956.288.
    • Next to the company Amyra Biotech AG there are 7 other active companies with an identical address. These include: Allcon AG, Bests AG, CanVirex AG.

    Commercial register information

    Source: SOGC

    Sector

    Research and development

    Purpose (Original language)

    Forschung, Entwicklung, Fabrikation und Vertrieb im Bereich von pharmazeutischen, medizinischen, biotechnologischen und verwandten Produkten sowie Erbringung von damit im Zusammenhang stehenden Dienstleistungen; vollständige Zweckumschreibung gemäss Statuten.

    Customise the company purpose with just a few clicks.

    Auditor

    Source: SOGC

    Current auditor (1)
    Name City Since Until
    Ernst & Young AG
    Basel 11.07.2017

    Would you like to adjust the auditors? Click here.

    Former auditor (1)
    Name City Since Until
    Caminada Revisions AG
    Zug 23.12.2014 10.07.2017

    Other company names

    Source: SOGC

    Es sind keine früheren oder übersetzten Firmannamen vorhanden.

    Would you like to update the company name? Click here.

    Branches (0)

    Ownership structure

    No information on the ownership structure is known to us.

    Holdings

    No information on holdings is known to us.

    Newest SOGC notifications: Amyra Biotech AG

    The latest updates from the Swiss Official Gazette of Commerce (SOGC) are available in the original language of the source commercial register office only. View all notifications

    SOGC 250714/2025 - 14.07.2025
    Categories: Change in capital

    Publication number: HR02-1006383647, Commercial Registry Office Basel-Stadt, (270)

    Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 164 vom 26.08.2024, Publ. 1006114055).

    Statutenänderung:
    15.11.2024. 02.07.2025.

    Aktienkapital neu:
    CHF 232'964.40 [bisher: CHF 222'496.92].

    Liberierung Aktienkapital neu:
    CHF 232'964.40 [bisher: CHF 222'496.92].

    Aktien neu:
    23'296'440 Namenaktien zu CHF 0.01 [bisher: 22'249'692 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband um CHF 10'467.48, wobei 27'748 Namenaktien zu CHF 0.01 durch Verrechnung von Forderungen in Höhe von CHF 60'770.00 liberiert werden. Die Gesellschaft hat mit Beschluss vom 15.11.2024 eine Erhöhung des bedingten Kapitals gemäss näherer Umschreibung in den Statuten beschlossen.

    SOGC 240826/2024 - 26.08.2024
    Categories: Change in capital

    Publication number: HR02-1006114055, Commercial Registry Office Basel-Stadt, (270)

    Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 111 vom 11.06.2024, Publ. 1006053624).

    Statutenänderung:
    15.08.2024.

    Aktienkapital neu:
    CHF 222'496.92 [bisher: CHF 210'439.55].

    Liberierung Aktienkapital neu:
    CHF 222'496.92 [bisher: CHF 210'439.55].

    Aktien neu:
    22'249'692 Namenaktien zu CHF 0.01 [bisher: 21'043'955 Namenaktien zu CHF 0.01]. Ordentliche Kapitalerhöhung innerhalb Kapitalband um CHF 12'057.37, wobei 1'165'226 Namenaktien zu CHF 0.01 durch Verrechnung von Forderungen in Höhe von CHF 2'709'747.37 liberiert werden.

    SOGC 240611/2024 - 11.06.2024
    Categories: Miscellaneous changes

    Publication number: HR02-1006053624, Commercial Registry Office Basel-Stadt, (270)

    Amyra Biotech AG, in Basel, CHE-321.956.288, Aktiengesellschaft (SHAB Nr. 129 vom 06.07.2023, Publ. 1005788737).

    Statutenänderung:
    05.06.2024. [Streichung der Statutenbestimmung über die mit Ermächtigungsbeschluss vom 15.06.2022 eingeführte genehmigte Kapitalerhöhung.] [gestrichen: Die Generalversammlung hat mit Beschluss vom 15.06.2022 genehmigtes Aktienkapital gemäss näherer Umschreibung in den Statuten geschaffen.]. Kapitalband gemäss näherer Umschreibung in den Statuten.

    Hit list

    Here you will find a link from the management to a hit list of persons with the same name who are registered in the commercial register.

    Title
    Confirm